Radiopharmaceutical CDMO Market with Highest growth in the near future by leading key players
The global radiopharmaceutical CDMO market is anticipated to grow at an estimated rate of around 9% over the next five years. This expansion is driven by the high costs and significant infrastructure requirements associated with in-house radiopharmaceutical production, the inherent complexity and time-critical nature of manufacturing radioactive compounds, rapid advancements in nuclear medicine technologies, and […]
Continue Reading